feature1

VIDEO: BDO’s Aftab Jamil Discusses Significant Changes in Life Sciences Financing

February 12, 2013 OneMedPlace Team 0

Aftab Jamil of BDO spoke with OneMedTV during the 6th Annual OneMedForum in January to discuss the state of life sciences investment, and how companies can formulate new strategies to attract a sustainable class of investors. At the core of these new strategies are the initiatives being implemented to increase access to non-venture capital in the earlier rounds, which may incubate a company long enough to grow a pipeline, attract tenable/diverse revenue opportunity, and eventually reach market.

March 2013: Santarus’ Uceris – Ulcerative Colitis

February 11, 2013 Vanessa Lane 0

Last month, Santarus, Inc’s Uceris for ulcerative colitis received FDA approval, and the company has announced a planned launch in March 2013. Santaurs has already begun adding 85 new positions to its sales staff in anticipation of Uceris’ future. The Uceris approval hopes to promise strong returns for a company with a checkered past, but a promising future.

VIDEO: Aptiv Solutions CEO Discusses Clinical Trials Guidelines, Unmet Need

February 8, 2013 OneMedPlace Team 0

Aside from re-defined financing structures, the most important issue facing life sciences EGCs is the need to increase clinical trial efficiency and productivity so that development budgets are used prudently to support products that have the best chance of market success. Speaking to OneMedTV during OneMedForum this past January, Donnelly discussed current changes that will impact the future of product development and the central role that innovative trial design will play in this.

2013, A Year for Point-of-Care Diagnostics Growth

February 4, 2013 Chelli Miller 0

Response Biomedical Corp. (RBM.TO)(RPBIF) is bringing in 2013 with a bang announcing their 2nd US distribution deal since the 1st week in January. Earlier in the month Response Biomedical entered a distribution agreement with US hospital supplier Laboratory Supply Company Inc. (Labsco) to distribute its cardiovascular portfolio of RAMP® products to small hospitals. By the end of January Response Biomedical announced their 2nd US distribution agreement with Fishers Healthcare for their RAMP® Flu A + B tests and RAMP® RSV test on the RAMP® 200.

No Image

Jan Medical’s Nautilus Neurowave Platform Could Be a Game-Changer for Quickly Identifying Stroke and Other Brain Abnormalities

January 29, 2013 OneMedPlace Team 0

Every 21 seconds, someone suffers a serious brain injury, such as a stroke, which is the third-leading cause of death in the United States and the leading cause of long-term disability. Today, Jan Medical is on the cusp of commercializing its first application of a revolutionary system, Nautilus NeurowaveTM, designed to help doctors quickly identify vasospasm and strokes.

No Image

CardioLogical Solutions Is “Accessorizing” a Potential $3 Billion Market by Making Transcatheter Aortic Valve Replacement “Truly Nonsurgical and Safer”

January 17, 2013 Vanessa Lane 0

Privately held CardioLogical Solutions is an emerging cardiovascular company formed this month by the merger of Emboline and VasoStitch. The company is developing a comprehensive suite of technologies that address the three biggest, and most pressing, clinical needs in order to make transcatheter aortic valve replacement (TAVR) procedures truly percutaneous and safer.

No Image

Can SpineGuard Shake-Up the $7 Billion Market for Spinal Fusion Using Screws with its Safety Oriented Technology?

January 7, 2013 OneMedPlace Team 0

SpineGuard, based in San Francisco and Paris, is addressing a major unmet need in spine surgery: the safe placement of pedicle screws for both patients and OR personnel. PediGuard®, its core technology, is the world’s first and only handheld device capable of alerting surgeons to potential pedicular or vertebral breaches during pedicle screw site preparation.